People: Novartis AG (NOVN.VX)
Dr. Charles L. Sawyers, M.D., has been Non-Executive Independent Member of the Board of Novartis AG since 2013. In the United States, Dr. Sawyers is chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center; professor of medicine and of cell and developmental biology at the Weill Cornell Graduate School of Medical Sciences; and an investigator at the Howard Hughes Medical Institute. He serves on U.S. President Barack Obama’s National Cancer Advisory Board, and is president-elect of the American Association of Cancer Research, and former president of the American Society for Clinical Investigation. He also is a member of the U.S. National Academy of Sciences and Institute of Medicine. Dr. Sawyers received his M.D. from the Johns Hopkins School of Medicine in the United States, and worked at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles for nearly 18 years before joining Memorial Sloan-Kettering in 2006. He is cancer researcher; and co developed the Novartis cancer drug Gleevec/Glivec, and has received numerous honors and awards, including the Lasker- DeBakey Clinical Medical Research Award in 2009. He was program chair at cancer treatment and research institution; member of U.S. cancer advisory board; president-elect of organization; former president of medical honor society.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|